Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AF, UK; Département de Psychiatrie et Neurosciences, Université Laval, Canada.
Early Psychosis: Interventions and Clinical-Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London SE5 8AF, UK; Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK; NIHR Oxford Health Biomedical Research Centre, Oxford OX3 7JX, UK; OPEN early detection service, Oxford Health NHS Foundation Trust, Oxford OX3 7JX, UK.
Neurosci Biobehav Rev. 2024 Jun;161:105669. doi: 10.1016/j.neubiorev.2024.105669. Epub 2024 Apr 9.
The effectiveness of universal preventive approaches in reducing the incidence of affective/psychotic disorders is unclear. We therefore aimed to synthesise the available evidence from randomised controlled trials. For studies reporting change in prevalence, we simulated all possible scenarios for the proportion of individuals with the disorder at baseline and at follow-up to exclude them. We then combined these data with studies directly measuring incidence and conducted random effects meta-analysis with relative risk (RR) to estimate the incidence in the intervention group compared to the control group. Eighteen studies (k=21 samples) were included investigating the universal prevention of depression in 66,625 individuals. No studies were available investigating universal prevention on the incidence of bipolar/psychotic disorders. 63 % of simulated scenarios showed a significant preventive effect on reducing the incidence of depression (k=9 - 19, RR=0.75-0.94, 95 %CIs=0.55-0.87,0.93-1.15, p=0.007-0.246) but did not survive sensitivity analyses. There is some limited evidence for the effectiveness of universal interventions for reducing the incidence of depression but not for bipolar/psychotic disorders.
普遍预防方法在降低情感/精神病障碍发生率方面的效果尚不清楚。因此,我们旨在综合随机对照试验的现有证据。对于报告患病率变化的研究,我们模拟了所有可能的基线和随访时患有该疾病的个体比例的情况,以将其排除在外。然后,我们将这些数据与直接测量发病率的研究相结合,并进行了随机效应荟萃分析,以估计干预组与对照组的发病率。共有 18 项研究(k=21 个样本)纳入了对 66625 人的抑郁的普遍预防研究。没有研究可用于调查双相情感/精神病障碍的普遍预防。63%的模拟情况显示出对降低抑郁症发病率的显著预防效果(k=9-19,RR=0.75-0.94,95%CI=0.55-0.87,0.93-1.15,p=0.007-0.246),但未通过敏感性分析。有一些有限的证据表明普遍干预措施在降低抑郁症发病率方面是有效的,但对双相情感/精神病障碍则无效。